Quetiapine

The Department is aware of the supply issues affecting several brands and tablet strengths of quetiapine modified release tablets. Following the Department working with suppliers, there have been improvements in the supply through February and early March, with improvements in supply expected to continue through to May, and full resolution expected in October 2025. The Department continues to work with the suppliers of quetiapine modified release tablets to bring forward these future deliveries. Working with National Health Service specialists, we have provided comprehensive management advice for this supply issue, advising healthcare professionals on how to manage patients during this time, and are providing up to date information on the availability of the impacted medicines. The Department continues to engage with representatives from the pharmacy sector on the supply of quetiapine modified-release tablets. Any patient who is worried about their condition, or access to these medications, should speak to their clinician in the first instance.